Skip to main navigation Skip to search Skip to main content

Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed chronic lymphocytic leukemia

  • P. Ghia
  • , S.E. Coutre
  • , R.R. Furman
  • , J.P. Sharman
  • , B.D. Cheson
  • , J.M. Pagel
  • , P. Hillmen
  • , J.C. Barrientos
  • , A.D. Zelenetz
  • , T.J. Kipps
  • , I.W. Flinn
  • , H.A. Eradat
  • , N. Lamanna
  • , B. Coiffier
  • , A. Pettitt
  • , X. Li
  • , T.M. Jahn
  • , S.M. OBrien
  • , M.J. Hallek

    Research output: Contribution to journal › Article › peer-review

    Original languageAmerican English
    JournalJournal of Geriatric Oncology
    Volume5
    DOIs
    StatePublished - Jan 10 2014

    Disciplines

    • Medicine and Health Sciences
    • Critical Care

    Cite this